The company’s CRISPR/Cas9 is a revolutionary technology for gene editing which is the process of precisely altering specific sequences of genomic DNA. It has a portfolio of therapeutic programs ...

Local success, global technology The CRISPR-Cas9 gene editing process complied ... but as a hopeful symbol of what Indian research can achieve. MC Science Desk Read the latest and trending science ...

Japanese researchers have successfully eliminated the extra chromosome responsible for Down syndrome using CRISPR gene ...

Amid a challenging gene editing climate, partnerships between researchers, regulators, and industry remain crucial for ...

Delve into what the new CRISPR tool, CAST, has to offer. CRISPR-associated transposases are already gaining traction in ...

While Casgevy is the first-ever approved CRISPR/Cas9 gene-edited therapy, its initial commercial uptake has been modest. Despite the groundbreaking nature of the therapy, Vertex recorded just $10 ...

Researchers from Tel Aviv University have developed a genetic editing method tailored to crop plants, which has influenced ...

CRISPR-Cas9 genome editing exploits the CRISPR-Cas system to modify a genome in a targeted manner. Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the ...

A newly discovered bacterial defense protein named Cat1 reveals an extraordinary method of viral neutralization. All living ...

Back in 1900 the life expectancy of people with Down Syndrome was 9 years. In 1984, it was 28 years, today it's leveled off between 50 and 60 ...